01 1Harnal
02 3Harnal/Omnic
03 1Omnic
Main Therapeutic Indication : Nephrology
Currency : USD
2020 Revenue in Millions : 351
2019 Revenue in Millions : 411
Growth (%) : -15
Main Therapeutic Indication : Nephrology
Currency : USD
2021 Revenue in Millions : 226
2020 Revenue in Millions : 349
Growth (%) : -30
Main Therapeutic Indication : Nephrology
Currency : USD
2022 Revenue in Millions : 69
2021 Revenue in Millions : 72
Growth (%) : -4
Main Therapeutic Indication : Nephrology
Currency : USD
2022 Revenue in Millions : 215
2021 Revenue in Millions : 227
Growth (%) : -5
Main Therapeutic Indication : Nephrology
Currency : USD
2019 Revenue in Millions : 417
2018 Revenue in Millions : 441
Growth (%) : -5